
GC26113
LY2880070
Also known as N-[5-(2-methoxy-6-methyl-3-pyridinyl)-1H-pyrazol-3-yl]-6-[(3R)-piperidin-3-yl]oxypyrazin-2-amine
LY2880070 is a new checkpoint kinase 1 (CHK1) inhibitor for cancer therapy
ChemicalCAS1375637-35-6MW381.43FormulaC19H23N7O2
- CAS number
- 1375637-35-6
- Molecular weight
- 381.43
- Formula
- C19H23N7O2
- Solubility
- DMSO: 60 mg/ml (157·3 mM) (< 1 mg/mL refers to the product slightly soluble or insoluble)
- InChIKey
- LAEFIEWPUJMANC-CYBMUJFWSA-N
- Catalogue number
- GC26113
- Brand
- GLPBIO
Computed properties PubChem CID 56968075 · XLogP 2 · TPSA 110 Ų · H-bond donors 3
- XLogP
- 2
- TPSA
- 110 Ų
- H-bond donors
- 3
- H-bond acceptors
- 8
- Rotatable bonds
- 6
- Heavy atoms
- 28
SMILES CC1=NC(=C(C=C1)C2=CC(=NN2)NC3=CN=CC(=N3)O[C@@H]4CCCNC4)OC
Computed descriptors from PubChem (CID 56968075), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il